Avivia

Avivia is a private, revenue-generating service provider in the pharmaceutical R&D sector, specializing in formulation development, analytical services, dissolution methods, and excipient analysis. Operating from Amsterdam, the company serves clients needing support in drug repurposing, reformulation, and reverse engineering, leveraging its integrated platforms to accelerate product development. Its business model is based on providing contract R&D services, generating IP for clients, and selecting optimal manufacturing partners, positioning it as a specialized intermediary in the drug development value chain.

Four integrated service platforms: 1) Formulation Development (API to product, reverse engineering, GMP batch manufacturing), 2) Analytical Services (chromatography, spectroscopy, mass spectrometry), 3) Dissolution Methods (predictive and biorelevant method development), and 4) Excipient Analysis (Excipia platform for physicochemical characterization of excipients).

Avivia competes in the fragmented pharmaceutical contract R&D market, facing competition from global full-service CROs (e.g., LabCorp, IQVIA), specialized formulation development shops, and analytical service laboratories. Its differentiation lies in its integrated four-platform approach and declared CMO independence, allowing it to position as an objective partner focused solely on development science.